NCT03467867 2025-12-24
A Study of Venetoclax and Rituximab/Hyaluronidase Human in Relapsed/Refractory CLL
Georgetown University
Phase 2 Active not recruiting
Clinical Trials
5 trialsNCT05099471 2025-11-28
VIWA-1
University of Ulm
Phase 2 Recruiting
NCT03422393 2024-07-05
Venetoclax With High-dose Ibrutinib for CLL Progressing on Single Agent Ibrutinib
University of California, San Diego
Phase 1 Active not recruiting
NCT06450145 2024-06-10
APL
Zhejiang Provincial People's Hospital
Phase NA Recruiting
NCT04092179 2024-01-24
ENAVEN-AML
University Health Network, Toronto
Phase 1/2 Terminated